发明授权
- 专利标题: Treatment of carcinomas using squalamine in combination with other anti-cancer agents
- 专利标题(中): 使用角鲨胺与其他抗癌剂联合治疗癌症
-
申请号: US840706申请日: 1997-04-25
-
公开(公告)号: US6147060A公开(公告)日: 2000-11-14
- 发明人: Michael Zasloff , Jon Williams
- 申请人: Michael Zasloff , Jon Williams
- 申请人地址: PA Plymouth Meeting
- 专利权人: Magainin Pharmaceuticals
- 当前专利权人: Magainin Pharmaceuticals
- 当前专利权人地址: PA Plymouth Meeting
- 主分类号: A61K45/00
- IPC分类号: A61K45/00 ; A61K31/00 ; A61K31/40 ; A61K31/407 ; A61K31/475 ; A61K31/505 ; A61K31/513 ; A61K31/575 ; A61K31/675 ; A61K31/70 ; A61K31/7028 ; A61K31/7034 ; A61K31/704 ; A61K31/7042 ; A61K31/7048 ; A61K31/7052 ; A61K31/706 ; A61K31/7064 ; A61K33/24 ; A61P35/00 ; A61K31/66 ; A61K31/175 ; A61K31/56
摘要:
A method for treating a tumor includes a first treatment procedure using a conventional cancer treatment technique, and a second treatment procedure which includes administering an effective amount of squalamine. The first treatment procedure may be a treatment with one or more conventional cytotoxic chemical compounds. As examples, the cytotoxic chemical compound may be a nitrosourea (such as BCNU), cyclophosphamide, adriamycin, 5-fluorouracil, paclitaxel and its derivatives, cisplatin or other platinum containing cancer treating agents. The cytotoxic chemical compound and the squalamine may be administered by any suitable route. The first treatment procedure may take place prior to the second treatment procedure, after the second treatment procedure, or the two treatment procedures may take place simultaneously. In one example, the first treatment procedure (e.g., a one time intravenous dosage of BCNU) is completed before the second treatment procedure with squalamine begins. As an alternative, the first treatment procedure may be a conventional radiation treatment regimen.
公开/授权文献
- USD345572S Daylight film loader 公开/授权日:1994-03-29
信息查询